Napa Therapeutics
Focused on a novel target linked to one of the fundamental processes of aging
Formed by the Buck Institute for Research on Aging, Insilico Medicine, and Juvenescence Ltd in 2018.
No company website as of July 2020.
Details last updated 14-Jul-2020
Mentioned in this Resource
Insilico Medicine
Biotechnology company that uses artificial intelligence to develop new drugs and for aging research
Napa Therapeutics News
Longevity.Technology interviews Buck Institute’s President and CEO Eric Verdin
Longevity Technology - 03-Oct-2019
Includes updates on NAPA Therapeutics and BHB Therapeutics
Read more...Aging focused biotechs forms AI based joint venture
FierceBiotech - 14-Aug-2018
Groundbreaking research biotechs performs aging research together for longevity
Read more...